RESP-X   Click here for help

GtoPdb Ligand ID: 14217

Synonyms: COT-143 | INFEX702
Compound class: Antibody
Comment: RESP-X is a humanized monoclonal antibody targeting the PcrV protein of Pseudomonas aeruginosa. It is being developed as an anti-virulence therapy for P. aeruginosa infections in patients with non-cystic fibrosis bronchiectasis.
No information available.
Summary of Clinical Use Click here for help
A phase 1 study has been registered with the UK's Clinical Study Registry (ID ISRCTN17978477) to evaluate the safety and efficacy of RESP-X in healthy subjects and non-cystic fibrosis bronchiectasis patients colonized with P. aeruginosa [1]. In addition, RESP-X (results presented at the American Thoracic Society (ATS) 2026 International Conference [2]).